Showing results (161-170 of 288) with videos related to

Sort By:
Pageof 29
Cancer|December 3, 2016
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 yearsPaul F Pinsky, Philip C Prorok, Kelly Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2006
A prospective study of lycopene and tomato product intake and risk of prostate cancerVictoria A Kirsh, Susan T Mayne, Ulrike Peters, et al.
European Urology|December 8, 2009
Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristicsBertrand Tombal, Kurt Miller, Laurent Boccon-Gibod, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
Aging Cell|June 5, 2009
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancerLisa Mirabello, Wen-Yi Huang, Jason Y Y Wong, et al.
International Journal of Clinical and Experimental Pathology|July 9, 2011
The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancerAl B Barqawi, Ruslan Turcanu, Eduard J Gamito, et al.
The Journal of Urology|May 7, 2018
Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with AntiandrogensE David Crawford, Paul F Schellhammer, David G McLeod, et al.
The Journal of Urology|July 27, 2011
A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancerE David Crawford, Bertrand Tombal, Kurt Miller, et al.
Therapeutic Advances in Urology|February 14, 2018
Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjectsDaniel Saltzstein, Neal D Shore, Judd W Moul, et al.
Urology|August 15, 2006
Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trialPaul F Pinsky, Barnett S Kramer, E David Crawford, et al.
Pageof 29